Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
World Journal of Clinical Cases|July 26, 2021
Corrigendum to "Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases"Li-Xuan SangWorld Journal of Gastroenterology|October 1, 2024
Dual-targeted treatment for inflammatory bowel disease: Whether fecal microbiota transplantation can be an important part of itZi-Ning Zhang, Li-Xuan SangWorld Journal of Gastroenterology|November 4, 2024
Elafibranor: A promising treatment for alcohol-associated liver disease?Hong Wei, Li-Xuan Sang, Bing ChangGastroenterology Report|November 9, 2020
Cronkhite-Canada syndrome: from clinical features to treatmentZe-Yu Wu, Li-Xuan Sang, Bing ChangWorld Journal of Gastrointestinal Surgery|March 10, 2023
Fecal microbiota transplantation as potential first-line treatment for patients with <i>Clostridioides difficile</i> infection and prior appendectomyJing-Wen Zhao, Bing Chang, Li-Xuan SangWorld Journal of Clinical Cases|June 18, 2020
Isoflavones and inflammatory bowel diseaseZe-Yu Wu, Li-Xuan Sang, Bing ChangMolecules (Basel, Switzerland)|March 25, 2017
Catechins and Their Therapeutic Benefits to Inflammatory Bowel DiseaseFei-Yan Fan, Li-Xuan Sang, Min JiangWorld Journal of Gastroenterology|July 10, 2024
Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritisBo-Tong Ma, Li-Xuan Sang, Bing ChangWorld Journal of Gastroenterology|February 5, 2024
Use of curcumin and its nanopreparations in the treatment of inflammatory bowel diseaseZi-Wen Meng, Bing Chang, Li-Xuan SangWorld Journal of Gastroenterology|January 8, 2024
Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1Yue-Hua Yin, Li-Xuan Sang, Bing ChangPageof 4